ANEST IWATA (6381) Q3 2025 earnings summary

Executive summary

• Net sales rose 2.6% year-over-year to 39,988 million yen, with operating profit up 3.1% to 4,633 million yen, but ordinary profit and net profit declined due to lower foreign exchange gains and valuation differences.

• Comprehensive income dropped 32.7% year-over-year to 4,605 million yen, reflecting weaker foreign currency translation and valuation differences.

• Full-year forecasts were revised downward due to slower-than-expected recovery in China, rising overseas labor costs, and mixed segment performance.

Financial highlights

• Net sales: 39,988 million yen (+2.6% YoY); operating profit: 4,633 million yen (+3.1% YoY); ordinary profit: 5,718 million yen (-2.3% YoY); net profit: 3,576 million yen (-1.6% YoY).

• Gross profit margin improved to 46.8% (+1.6 pts YoY); gross profit reached 18,724 million yen.

• Equity ratio improved to 69.0% (+2.2 pts from previous year-end).

• Dividends paid per share increased to 27.0 yen (year-end) and 22.0 yen (interim), with a revised annual forecast of 45.0 yen.

• Total assets stood at 65,726 million yen (down 0.6% from March 31, 2024), while net assets rose 3.2% to 51,675 million yen.

Outlook and guidance

• Revised FY2024 net sales forecast to 54,500 million yen (-6.0% from initial), operating profit to 5,700 million yen (-16.2%), and net profit to 4,400 million yen (-11.1%).

• Dividend forecast reduced to 45 yen per share, maintaining a payout ratio near 40%.

• Basic earnings per share for the full year is projected at 111.17 yen.

• The company notes that actual results may differ significantly due to various factors.